Özcan MA - Search Results

1

Nilotinib Does Not Alter the Secretory Functions of Carotid Artery Endothelial Cells in a Prothrombotic or Antithrombotic Fashion.

Katgı A, Sevindik ÖG, Gökbulut AA, Özsan GH, Yüksel F, Solmaz ŞM, Alacacıoğlu İ, Özcan MA, Demirkan F, Baran Y, Pişkin Ö. Katgı A, et al. Among authors: ozcan ma. Clin Appl Thromb Hemost. 2015 Oct;21(7):678-83. doi: 10.1177/1076029614550817. Epub 2014 Sep 18. Clin Appl Thromb Hemost. 2015. PMID: 25239946 Free article.

2

Effect of granulocyte-colony-stimulating factor on serum lactate dehydrogenase levels and isoenzymes in a rabbit model.

Menekay S, Ozsan GH, Demirkan F, Ozbek D, Ozcan MA, Fadíloğlu M, Undar B. Menekay S, et al. Among authors: ozcan ma. Acta Haematol. 2002;107(1):18-22. doi: 10.1159/000046624. Acta Haematol. 2002. PMID: 11818667

3

Hemophagocytic syndrome associated with inappropiate secretion of antidiuretic hormone in lymphoma and acute myeloblastic leukemia: report of two cases.

Demirkan F, Vural F, Ozsan GH, Ozcan MA, Ozkal S, Undar B. Demirkan F, et al. Among authors: ozcan ma. Leuk Lymphoma. 2001 Nov-Dec;42(6):1401-4. doi: 10.3109/10428190109097769. Leuk Lymphoma. 2001. PMID: 11911425

4

EBV-associated nasal-type T/natural killer cell lymphoma presenting with polyserositis and rhabdomyolysis.

Vural F, Demirkan F, Ozsan GH, Kargi A, Cabuk M, Ozcan MA, Sayan M, Ozkal S, Cehreli C, Undar B. Vural F, et al. Among authors: ozcan ma. Leuk Lymphoma. 2002 Sep;43(9):1859-63. doi: 10.1080/1042819021000006376. Leuk Lymphoma. 2002. PMID: 12685845

5

Plasma levels of free tissue factor pathway inhibitor in patients with various thyroid disorders.

Ozcan MA, Cömlekçi A, Demirkan F, Yüksel F, Sari I, Demir T, Ozsan GH, Orük G, Yeşil S, Undar B. Ozcan MA, et al. Thromb Res. 2003 Jun 1;110(4):243-7. doi: 10.1016/s0049-3848(03)00408-0. Thromb Res. 2003. PMID: 14512089

6

Gingival involvement in a patient with CD56+ chronic myelomonocytic leukemia.

Vural F, Ozcan MA, Ozsan GH, Demirkan F, Piskin O, Ates H, Kargi A, Undar B. Vural F, et al. Among authors: ozcan ma. Leuk Lymphoma. 2004 Feb;45(2):415-8. doi: 10.1080/1042819031000139639. Leuk Lymphoma. 2004. PMID: 15101735

7

Plasma levels of thrombin activatable fibrinolysis inhibitor in normal and preeclamptic pregnant women.

Alacacioğlu I, Ozcan MA, Alacacioğlu A, Polat M, Yüksel F, Demirkan F, Pişkin O, Ozgenç Y, Ozsan HG, Undar B. Alacacioğlu I, et al. Among authors: ozcan ma. Thromb Res. 2004;114(3):155-9. doi: 10.1016/j.thromres.2004.05.012. Thromb Res. 2004. PMID: 15342211 Clinical Trial.

8

Cyclo-oxygenase 2 inhibitor, nabumetone, inhibits proliferation in chronic myeloid leukemia cell lines.

Vural F, Ozcan MA, Ozsan GH, Ateş H, Demirkan F, Pişkin O, Undar B. Vural F, et al. Among authors: ozcan ma. Leuk Lymphoma. 2005 May;46(5):753-6. doi: 10.1080/10428190400027860. Leuk Lymphoma. 2005. PMID: 16019514

9

Bilateral primary orbital non-Hodgkin's lymphoma in a patient with scleroderma: a case report.

Alacacioglu I, Ozcan MA, Kocak N, Demiral A, Piskin O, Demirkan F, Ozsan GH, Saatci AO, Undar B. Alacacioglu I, et al. Among authors: ozcan ma. Leuk Lymphoma. 2005 Aug;46(8):1239-42. doi: 10.1080/10428190500097748. Leuk Lymphoma. 2005. PMID: 16085569

10

Usefulness of preprocedural soluble CD40 ligand for predicting restenosis after percutaneous coronary intervention in patients with stable coronary artery disease.

Türker S, Güneri S, Akdeniz B, Ozcan MA, Baris N, Badak O, Kirimli O, Yüksel F. Türker S, et al. Among authors: ozcan ma. Am J Cardiol. 2006 Jan 15;97(2):198-202. doi: 10.1016/j.amjcard.2005.08.024. Epub 2005 Nov 21. Am J Cardiol. 2006. PMID: 16442363

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82 results

Search Page

Filters